ARYNX | MGLCX | ARYNX / MGLCX | |
Total Expense Ratio | 0.92 | 1.94 | 47% |
Annual Report Gross Expense Ratio | 0.92 | 1.95 | 47% |
Fund Existence | 14 years | 11 years | - |
Gain YTD | 3.941 | 3.043 | 129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 1000 | 500,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 858M | 2.22B | 39% |
Annual Yield % from dividends | 2.28 | 1.29 | 177% |
Returns for 1 year | 8.07 | 1.39 | 579% |
Returns for 3 years | 14.62 | -6.36 | -230% |
Returns for 5 years | 29.36 | 9.38 | 313% |
Returns for 10 years | 53.02 | 9.12 | 581% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HAGIX | 83.44 | 0.75 | +0.91% |
Carillon Eagle Mid Cap Growth I | |||
GLCTX | 32.10 | 0.19 | +0.60% |
Goldman Sachs Large Cap Gr Insghts Inv | |||
BUFEX | 58.96 | 0.22 | +0.37% |
Buffalo Blue Chip Growth | |||
GCVTX | 24.41 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts Inv | |||
LHCCX | 17.55 | 0.05 | +0.29% |
Lord Abbett Health Care C |